Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Randomized Controlled Trial of Neuroprotection with Lamotrigine in Secondary Progressive Multiple Sclerosis
MS and Related Diseases
(-)
003
Authors/Disclosures
Raju Kapoor, MD No disclosure on file
No disclosure on file
Tom Hayton (Institute Of Technology) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Robert Brenner, FRCP (Royal Free Hospital) No disclosure on file
Jeremy S. Chataway, MD Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NerveGen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Richard A. Hughes, MD Dr. Hughes has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hansa Biopharma. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic.
David H. Miller, MD, MBChB, FRCP (Univ Dept of Clinical Neuro) No disclosure on file